Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check5 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, signaling a page update. This change does not modify the study content or details presented.SummaryDifference0.1%

- Check12 days agoChange DetectedThe page now includes a 'Multiple myeloma' entry and related topics such as MedlinePlus Genetics, and the site revision label updates from v3.6.0 to v3.6.2.SummaryDifference0.2%

- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedRecruitment status is updated to 'No longer looking for participants', indicating enrollment for the study is closed. The page also adds or updates navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the revision to v3.6.0.SummaryDifference0.6%

- Check34 days agoChange DetectedMultiple myeloma was added as a condition and MedlinePlus Genetics was added as a related topic. The revision tag was updated from v3.5.4 to v3.5.5.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page no longer displays the disease keyword and its related topics section, removing access to the associated resources for this condition.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now lists 'Multiple myeloma' as a condition and includes related topics such as MedlinePlus Genetics, expanding navigational context for readers. The site revision was updated to v3.5.4, replacing the previous v3.5.3.SummaryDifference0.2%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.